PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
+4.58%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$663M
AUM Growth
+$663M
(+5.5%)
Cap. Flow
+$163K
Cap. Flow
% of AUM
0.02%
Top 10 Holdings %
Top 10 Hldgs %
47.41%
Holding
224
New
41
Increased
20
Reduced
31
Closed
32
Top Buys
| 1 |
United Therapeutics
UTHR
|
$13.5M |
| 2 |
Cytokinetics
CYTK
|
$12.6M |
| 3 |
Illumina
ILMN
|
$10.5M |
| 4 |
ICU Medical
ICUI
|
$9.41M |
| 5 |
OLK
Olink Holding AB (publ) American Depositary Shares
OLK
|
$7.52M |
Top Sells
| 1 |
Biogen
BIIB
|
$25.8M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$13.9M |
| 3 |
Pulmonx
LUNG
|
$9.13M |
| 4 |
NSTG
NanoString Technologies, Inc.
NSTG
|
$9.01M |
| 5 |
Evolent Health
EVH
|
$7.06M |
Sector Composition
| 1 | Healthcare | 90.69% |
| 2 | Industrials | 0.83% |
| 3 | Materials | 0.39% |
| 4 | Consumer Staples | 0% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Establishment Labs
ESTA
$1.2B
| $52.2M | 3.02% | 956,745 -31,968 | -3% | -$1.75M |
|
|
VRAY
2
DELISTED
ViewRay, Inc.
VRAY
| $49.7M | 2.88% | 13,664,939 -204,169 | -1% | -$743K |
|
|
CUTR
3
DELISTED
Cutera, Inc.
CUTR
| $46.4M | 2.69% | 1,018,619 -99,539 | -9% | -$4.54M |
|
4
Glaukos
GKOS
$5.5B
| $37.5M | 2.17% | 704,412 -92,188 | -12% | -$4.91M |
|
5
Inspire Medical Systems
INSP
$2.77B
| $35.8M | 2.07% | 201,584 -2,881 | -1% | -$511K |
|
|
6
United Therapeutics
UTHR
$13.8B
| $26.2M | 1.51% | 125,046 +64,396 | +106% | +$13.5M |
|
7
Guardant Health
GH
$8.41B
| $21.6M | 1.25% | 400,984 -68,508 | -15% | -$3.69M |
|
|
ISEE
8
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $17.5M | 1.01% | 975,430 +260,286 | +36% | +$4.67M |
|
9
Outset Medical
OM
$247M
| $14.4M | 0.83% | 904,619 +460,918 | +104% | +$7.34M |
|
|
IMDX
10
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $13.2M | 0.76% | 18,056,274 | – | – |
|
|
11
Pulmonx
LUNG
$69.7M
| $13M | 0.75% | 778,978 -548,087 | -41% | -$9.13M |
|
12
Lyra Therapeutics
LYRA
$11.5M
| $12.6M | 0.73% | 2,510,302 -65,894 | -3% | -$330K |
|
|
13
Cytokinetics
CYTK
$4.23B
| $12.6M | 0.73% | +15,000 | New | +$12.6M |
|
14
LivaNova
LIVN
$3.08B
| $12.3M | 0.71% | 243,089 -13,759 | -5% | -$699K |
|
15
STAAR Surgical
STAA
$1.36B
| $12.2M | 0.71% | 173,310 -22,500 | -11% | -$1.59M |
|
16
KalVista Pharmaceuticals
KALV
$678M
| $12.1M | 0.7% | 832,702 +19,874 | +2% | +$288K |
|
|
17
Illumina
ILMN
$15.8B
| $10.5M | 0.61% | +55,000 | New | +$10.5M |
|
|
NSTG
18
DELISTED
NanoString Technologies, Inc.
NSTG
| $9.75M | 0.56% | 763,700 -705,847 | -48% | -$9.01M |
|
19
AstraZeneca
AZN
$248B
| $9.6M | 0.56% | 175,000 +12,172 | +7% | +$668K |
|
|
20
ICU Medical
ICUI
$3.15B
| $9.41M | 0.54% | +62,500 | New | +$9.41M |
|
21
Lantheus
LNTH
$3.73B
| $8.7M | 0.5% | 123,765 -88,473 | -42% | -$6.22M |
|
22
Cytek Biosciences
CTKB
$527M
| $7.76M | 0.45% | 527,164 +50,000 | +10% | +$736K |
|
23
Vertex Pharmaceuticals
VRTX
$100B
| $7.75M | 0.45% | 26,763 +10,000 | +60% | +$2.9M |
|
|
OLK
24
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $7.52M | 0.44% | +619,723 | New | +$7.52M |
|
25
TG Therapeutics
TGTX
$4.65B
| $7.11M | 0.41% | 1,200,813 +250,000 | +26% | +$1.48M |
|